Well the catch up didn't take long despite the many posts from so few with the same things to say .Select the view thread button and skim through , it only takes a few seconds per thread.
It seems that we may be entering a drought as far as announcements are concerned. Or are we ?
I'm not expecting any thing from Novartis or the FDA for a while however I would think it possible to get a further update on the biomarker annalases of the COVID ARDS trial. This could be a published review. There remains a lot of interest in Covid and the treatments.
As investors there is still a lot of data from the CHF trial unknown. We look forward to a article to.be published in the NEJM.
FDA will be in the spotlight, Senate having a very close look at the process and a boss to be found. Change is in the wind.
Plenty to look forward to,
Good luck all
MSB Trading 2021 - paradigm shift, page-7631
-
- There are more pages in this discussion • 2,580 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |